RxDoctor Payments Data

John Tanner, MD

Family Medicine · Raleigh, NCNPI 1699983411

Payments from drug & device makers

$1,233in general payments, 2019–2025

Across 79 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$530
  • Lilly USA, LLC$252
  • Pfizer$110
  • Sanofi-aventis U.S. LLC$66
  • AstraZeneca$54
  • Amarin Pharma, Inc.$45
  • plus $176 from 8 others

What the payments were for

  • Food & beverage$1,233100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,233 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$40,111
Medicare patients
101
Services billed
554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide19$22,441
Xtampza ErOxycodone Myristate24$19,537
OzempicSemaglutide13$18,481
EliquisApixaban18$18,364
JanuviaSitagliptin Phosphate12$17,673
FarxigaDapagliflozin Propanediol19$15,779
JardianceEmpagliflozin14$13,338
Atorvastatin Calcium153$1,674
Nano 2nd Gen Pen NeedlePen Needle, Diabetic15$1,374
Oxycodone Hcl19$1,237
Rosuvastatin Calcium60$790
Gabapentin43$760
Valsartan47$752
SynthroidLevothyroxine Sodium12$694
Lisinopril63$665

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$252$22,44119 claims
Novo NordiskOzempic$530$18,48113 claims
PfizerEliquis$110$18,36418 claims
MerckJanuvia$26$17,67312 claims
AstraZenecaFarxiga$54$15,77919 claims
Boehringer IngelheimJardiance$16$13,33814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →